Holen Sie sich die Stockscreener-App
38.10
4.00%
-1.51
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ARWR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$39.61
Offen:
$38.6
24-Stunden-Volumen:
951.43K
Relative Volume:
0.41
Marktkapitalisierung:
$5.26B
Einnahmen:
$181.74M
Nettoeinkommen (Verlust:
$-143.97M
KGV:
-27.41
EPS:
-1.39
Netto-Cashflow:
$9.60M
1W Leistung:
-3.86%
1M Leistung:
+5.27%
6M Leistung:
+163.70%
1J Leistung:
+89.56%
1-Tages-Spanne:
$37.77
$39.31
1-Wochen-Bereich:
$37.77
$43.69
52-Wochen-Spanne:
$9.57
$43.69
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
Firmenname
Arrowhead Pharmaceuticals Inc
Sektor
Branche
Telefon
626-696-4702
Adresse
177 E COLORADO BLVD, PASADENA, CA
Vergleichen Sie ARWR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
38.06 | 5.48B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.53 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.36 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.23 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.14 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.80 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-05 | Eingeleitet | Goldman | Neutral |
| 2023-12-04 | Eingeleitet | BofA Securities | Buy |
| 2023-09-19 | Eingeleitet | Citigroup | Neutral |
| 2023-07-21 | Eingeleitet | TD Cowen | Outperform |
| 2023-05-12 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2023-04-26 | Eingeleitet | SMBC Nikko | Outperform |
| 2023-04-12 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-11 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-19 | Fortgesetzt | Goldman | Buy |
| 2021-08-06 | Bestätigt | Chardan Capital Markets | Buy |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-19 | Eingeleitet | Citigroup | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-03-24 | Hochstufung | SVB Leerink | Underperform → Mkt Perform |
| 2020-03-17 | Eingeleitet | Goldman | Neutral |
| 2020-01-21 | Eingeleitet | SVB Leerink | Underperform |
| 2019-12-13 | Eingeleitet | Oppenheimer | Perform |
| 2019-11-29 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-11-27 | Bestätigt | B. Riley FBR | Buy |
| 2019-11-25 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-22 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-10-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-09-07 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-09-06 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-08-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-07-02 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Arrowhead Pharmaceuticals Inc Aktie (ARWR) Neueste Nachrichten
Why Arrowhead Pharmaceuticals Inc. is moving todayQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Can Arrowhead Pharmaceuticals Inc. stock sustain revenue growth2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
Arrowhead (NASDAQ: ARWR) to present fazirsiran, zodasiran at AHA/AASLD; Jefferies, TD Cowen - Stock Titan
Will Arrowhead Pharmaceuticals Inc. stock gain from lower inflationQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
Advanced analytics toolkit walkthrough for Arrowhead Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
How sentiment analysis helps forecast Arrowhead Pharmaceuticals Inc.Market Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Trend analysis for Arrowhead Pharmaceuticals Inc. this week2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Will Arrowhead Pharmaceuticals Inc. stock continue dividend increasesWeekly Stock Report & Smart Swing Trading Techniques - newser.com
How to escape a deep drawdown in Arrowhead Pharmaceuticals Inc.Quarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
Hypertriglyceridemia: Clinical Landscape, Companies, Therapeutic Assessment, Treatment Algorithm, and Pipeline Insights | Key Players: NorthSea Therapeutics, Arrowhead Pharmaceuticals, Zhejiang Doer B - Barchart.com
Risk vs reward if holding onto Arrowhead Pharmaceuticals Inc.Market Performance Summary & Advanced Technical Analysis Signals - newser.com
Is Arrowhead Pharmaceuticals Inc. stock cheap at current valuationMarket Sentiment Report & Technical Pattern Alert System - newser.com
What dividend safety rating applies to Arrowhead Pharmaceuticals Inc. (HDP1) stockJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Will Arrowhead Pharmaceuticals Inc. stock benefit from upcoming earnings reportsMarket Risk Report & Reliable Price Breakout Signals - newser.com
What makes Arrowhead Pharmaceuticals Inc. (HDP1) stock appealing to growth investors2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Will Arrowhead Pharmaceuticals Inc. stock split again soonMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Why Arrowhead Pharmaceuticals Inc. (HDP1) stock signals breakout potential2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Pinnacle Associates Ltd. Purchases 70,399 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat
How Arrowhead Pharmaceuticals Inc. (HDP1) stock behaves under inflation pressureEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
How to build a dashboard for Arrowhead Pharmaceuticals Inc. stockJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Targeted Drug Delivery Market Set to Witness Massive Growth - openPR.com
Is Arrowhead Pharmaceuticals Inc. showing signs of accumulation2025 Price Momentum & Risk Managed Trade Strategies - newser.com
Why analysts remain bullish on Arrowhead Pharmaceuticals Inc. stockWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Can Arrowhead Pharmaceuticals Inc. stock hit analyst price targets2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Is Arrowhead Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Best data tools to analyze Arrowhead Pharmaceuticals Inc. stockQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Can Arrowhead Pharmaceuticals Inc. stock reach $100 price targetEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):